Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin-Reference-Cited by-同舟云学术

Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin

Published:2010 Issue: Volume: Page:NA-NA
ISSN:0360-4012
Container-title:Journal of Neuroscience Research
language:en
Short-container-title:J. Neurosci. Res.

Author:

Li Chao,Biswas S.,Li Xingang,Dutta A.K.,Le Weidong

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference37 articles.

1. Brainderived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta;Baquet;J Neurosci,2005

2. Dopamine modulates effort-based decision making in rats;Bardgett;Behav Neurosci,2009

3. Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity;Biswas;J Med Chem,2008

4. Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl] propylamino}-5,6,7,8-tetrahydronaphtha len-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action;Biswas;J Med Chem,2008

5. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms;Block;Nat Rev Neurosci,2007

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Further exploration of N-4 substituents on the piperazine ring of the hybrid template 5/ 7-{[2-(4-Aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol and its analog: development of an exceptionally potent agonist for D2 & D3 receptors;Medicinal Chemistry Research;2024-08-08

2. Dopamine Receptor Ligand Selectivity—An In Silico/In Vitro Insight;Biomedicines;2023-05-17

3. Neuroprotective effect of secukinumab against rotenone induced Parkinson's disease in rat model: Involvement of IL-17, HMGB-1/TLR4 axis and BDNF/TrKB cascade;International Immunopharmacology;2023-01

4. Recent advances in dopamine D ₂ receptor ligands in the treatment of neuropsychiatric disorders;Medicinal Research Reviews;2022-09-16

5. Acid‐Catalyzed Synthesis of Diverse Indol‐3‐Yl‐Substituted Tetrahydropyridines through Three‐Component Reactions;Advanced Synthesis & Catalysis;2022-07-26